Russell Investments Group
ATRA icon

Russell Investments Group’s Atara Biotherapeutics ATRA Stock Holding History

Russell Investments Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-368
Closed -$2.19K – 3845
2025
Q1 		$2.19K Sell
368
-351
-49% -$3.06K ﹤0.01% 3503
2024
Q4 		$9.57K Hold
719
– – ﹤0.01% 3143
2024
Q3 		$5.84K Buy
719
+717
+35,850% +$6.14K ﹤0.01% 3187
2024
Q2 		$17 Buy
+2
New +$30 ﹤0.01% 3570
2023
Q4 		– Sell
-6
Closed -$226 – 3213
2023
Q3 		$226 Sell
6
-222
-97% -$9.88K ﹤0.01% 3479
2023
Q2 		$9.19K Hold
228
– – ﹤0.01% 2978
2023
Q1 		$16.6K Buy
+228
New +$22.1K ﹤0.01% 2838
2021
Q3 		– Sell
-836
Closed -$324K – 3041
2021
Q2 		$324K Sell
836
-78
-9% -$27.8K ﹤0.01% 2749
2021
Q1 		$327K Buy
+914
New +$404K ﹤0.01% 2679
2020
Q4 		– Sell
-1,017
Closed -$328K – 3038
2020
Q3 		$328K Sell
1,017
-57
-5% -$19.4K ﹤0.01% 2578
2020
Q2 		$390K Buy
+1,074
New +$271K ﹤0.01% 2479
2020
Q1 		– Sell
-2,021
Closed -$830K – 3029
2019
Q4 		$830K Hold
2,021
– – ﹤0.01% 2200
2019
Q3 		$712K Buy
+2,021
New +$754K ﹤0.01% 2160
2017
Q4 		– Sell
-410
Closed -$170K – 2951
2017
Q3 		$170K Buy
+410
New +$155K ﹤0.01% 2697
2017
Q2 		– Sell
-61
Closed -$31K – 2962
2017
Q1 		$31K Sell
61
-220
-78% -$91.1K ﹤0.01% 2940
2016
Q4 		$101K Buy
+281
New +$119K ﹤0.01% 2877

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group's ATRA Position: Q2 2025 in Review

Russell Investments Group sold out of Atara Biotherapeutics (ATRA) in Q2 2025, closing a stake of 368 shares — an estimated $2.19K sold.

Russell Investments Group first reported a position in ATRA in Q4 2016 and held it in 16 quarters. The position peaked at $830K in Q4 2019. 32 funds tracked by Wall St. Rank hold ATRA as of Q2 2025.

  • Russell Investments Group reported no remaining Atara Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 368 Atara Biotherapeutics shares in Q2 2025, an estimated $2.19K.
  • Russell Investments Group first reported a position in Atara Biotherapeutics in Q4 2016 and held it in 16 quarters.
  • Russell Investments Group's Atara Biotherapeutics position peaked at $830K in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.